Ready Capital (RC) Price Target Reduced by 11.43% to $3.95
Price Target Revision: The average one-year price target for Ready Capital (NYSE:RC) has been lowered to $3.95 per share, an 11.43% decrease from the previous estimate of $4.46, with current targets ranging from $2.52 to $6.30 per share.
Fund Sentiment: There are 449 funds reporting positions in Ready Capital, a decrease of 28 funds (5.87%) from the last quarter, with total shares owned by institutions down 9.45% to 124,147K shares.
Shareholder Activity: Major shareholders like IJR and VTSMX have reduced their portfolio allocations in RC, while Invesco increased its holdings but significantly decreased its allocation percentage.
Market Outlook: The put/call ratio for RC stands at 0.27, indicating a bullish sentiment among investors.
Trade with 70% Backtested Accuracy
Analyst Views on RC
About RC
About the author
Ready Capital to Release 2025 Financial Results
- Earnings Release Schedule: Ready Capital Corporation plans to release its fourth quarter and full year 2025 financial results after the NYSE closes on February 26, 2026, which is expected to provide crucial financial data and business updates for investors.
- Webcast and Conference Call: Management will host a webcast and conference call on February 27, 2026, at 8:30 a.m. Eastern Time, aimed at discussing financial results and providing a business overview, thereby enhancing transparency and investor confidence.
- Access Instructions: The company encourages investors to participate via the webcast to avoid potential long wait times when dialing in, ensuring smooth access to information and participation in discussions.
- Replay Information: A replay of the call will be available on the company's website approximately two hours after the live call, continuing until March 13, 2026, allowing investors who could not attend live to access key information.
Travere Therapeutics Issues 2026 Outlook, Shares Plunge 28.2%
- Sales Forecast Downgrade: Travere Therapeutics expects U.S. net product sales of $410 million for 2025 and $127 million for Q4 2026, indicating pressure on future revenue growth that could undermine investor confidence.
- Clinical Trial Restart: The company plans to restart the Phase 3 HARMONY study in Q1 2026, aiming to advance product development, but this may not alleviate the short-term stock price decline.
- Severe Market Reaction: Shares of Travere Therapeutics plummeted 28.2% to $24.50 in pre-market trading, reflecting a pessimistic outlook from the market that may lead investors to reassess their strategies.
- Other Stock Volatility: Lulu’s Fashion Lounge Holdings surged 79% on acquisition news but fell 10.4% in pre-market trading, highlighting the high volatility in market sentiment that could impact the overall investment landscape.
Heritage Global Inc (HGBL) Acquires Debt Exchange Assets, Shares Surge 19.1%
- Significant Stock Surge: Heritage Global Inc's shares rose 19.1% to $1.62 in pre-market trading, reflecting strong market confidence in the company's growth potential following the acquisition announcement.
- Acquisition Details: The company's subsidiary, Heritage DebtX, acquired substantially all assets of The Debt Exchange, which not only strengthens its asset base but also enhances its competitive position in the debt trading market.
- Strong Market Reaction: The acquisition news generated significant investor interest, with Heritage Global's stock performing notably well in pre-market trading, indicating market approval of its strategic direction.
- Future Growth Potential: This acquisition positions Heritage Global to capture a larger market share in debt management and trading, potentially leading to long-term revenue growth and business expansion opportunities.
Three Financial Stocks Poised for Significant Growth This Month
Oversold Stocks Opportunity: The financial sector has several oversold stocks, identified by a Relative Strength Index (RSI) below 30, indicating potential buying opportunities for undervalued companies.
Noah Holdings Performance: Noah Holdings reported strong quarterly sales with a significant year-over-year profit increase, yet its stock fell 10% recently, closing at $9.64 with an RSI of 26.1.
Ready Capital Challenges: Ready Capital's third-quarter results were disappointing, leading to a 12% stock decline, closing at $2.22, and an RSI of 26.1, as the company focuses on restoring financial health.
X Financial's Decline: X Financial experienced a 41% drop in stock price over the past month, closing at $6.63 with an RSI of 25.2, despite reporting a year-over-year revenue increase but facing operational challenges.
Lightwave Logic, Kyverna Therapeutics, and Other Major Stocks Decline in Tuesday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are down, with Dow futures falling approximately 0.2% on Tuesday morning.
Lightwave Logic Inc: Shares of Lightwave Logic Inc dropped 14.5% to $3.22 in pre-market trading following the announcement of a $35 million public offering.
Other Declining Stocks: Several other stocks also saw declines in pre-market trading, including Ascent Solar Technologies (-15.1%), Fractyl Health (-10.4%), and Ready Capital (-9%).
Market Overview: The overall market sentiment appears negative, with multiple companies reporting significant drops in their stock prices ahead of the trading day.
Major Stock Movers on Tuesday: RILY, ORGO, KYTX, RC, LWLG, and Others
Market Overview: U.S. stock futures declined as investors remained cautious ahead of November's employment data, a crucial indicator for the labor market's health.
Biggest Gainers: B. Riley Financial shares surged by 28.5% after filing its overdue Q2 report, revealing a return to profitability, while Organogenesis Holdings rose 7.5% following FDA confirmation to initiate a rolling Biologics License Application for its knee osteoarthritis treatment.
Biggest Losers: Fractyl Health's shares fell 10.71% due to the cancellation of Tranche A warrants, and Kyverna Therapeutics dropped 6.7% after announcing a $100 million public offering despite positive clinical data.
Dividend Cuts and Offerings: Ready Capital's shares declined 9.44% after a drastic 92% dividend cut, and Lightwave Logic's stock slid 14.59% following the pricing of a $35 million public offering to boost cash reserves for commercialization and strategic purposes.
Ready Capital to Release 2025 Financial Results
- Earnings Release Schedule: Ready Capital Corporation plans to release its fourth quarter and full year 2025 financial results after the NYSE closes on February 26, 2026, which is expected to provide crucial financial data and business updates for investors.
- Webcast and Conference Call: Management will host a webcast and conference call on February 27, 2026, at 8:30 a.m. Eastern Time, aimed at discussing financial results and providing a business overview, thereby enhancing transparency and investor confidence.
- Access Instructions: The company encourages investors to participate via the webcast to avoid potential long wait times when dialing in, ensuring smooth access to information and participation in discussions.
- Replay Information: A replay of the call will be available on the company's website approximately two hours after the live call, continuing until March 13, 2026, allowing investors who could not attend live to access key information.
Travere Therapeutics Issues 2026 Outlook, Shares Plunge 28.2%
- Sales Forecast Downgrade: Travere Therapeutics expects U.S. net product sales of $410 million for 2025 and $127 million for Q4 2026, indicating pressure on future revenue growth that could undermine investor confidence.
- Clinical Trial Restart: The company plans to restart the Phase 3 HARMONY study in Q1 2026, aiming to advance product development, but this may not alleviate the short-term stock price decline.
- Severe Market Reaction: Shares of Travere Therapeutics plummeted 28.2% to $24.50 in pre-market trading, reflecting a pessimistic outlook from the market that may lead investors to reassess their strategies.
- Other Stock Volatility: Lulu’s Fashion Lounge Holdings surged 79% on acquisition news but fell 10.4% in pre-market trading, highlighting the high volatility in market sentiment that could impact the overall investment landscape.
Heritage Global Inc (HGBL) Acquires Debt Exchange Assets, Shares Surge 19.1%
- Significant Stock Surge: Heritage Global Inc's shares rose 19.1% to $1.62 in pre-market trading, reflecting strong market confidence in the company's growth potential following the acquisition announcement.
- Acquisition Details: The company's subsidiary, Heritage DebtX, acquired substantially all assets of The Debt Exchange, which not only strengthens its asset base but also enhances its competitive position in the debt trading market.
- Strong Market Reaction: The acquisition news generated significant investor interest, with Heritage Global's stock performing notably well in pre-market trading, indicating market approval of its strategic direction.
- Future Growth Potential: This acquisition positions Heritage Global to capture a larger market share in debt management and trading, potentially leading to long-term revenue growth and business expansion opportunities.
Three Financial Stocks Poised for Significant Growth This Month
Oversold Stocks Opportunity: The financial sector has several oversold stocks, identified by a Relative Strength Index (RSI) below 30, indicating potential buying opportunities for undervalued companies.
Noah Holdings Performance: Noah Holdings reported strong quarterly sales with a significant year-over-year profit increase, yet its stock fell 10% recently, closing at $9.64 with an RSI of 26.1.
Ready Capital Challenges: Ready Capital's third-quarter results were disappointing, leading to a 12% stock decline, closing at $2.22, and an RSI of 26.1, as the company focuses on restoring financial health.
X Financial's Decline: X Financial experienced a 41% drop in stock price over the past month, closing at $6.63 with an RSI of 25.2, despite reporting a year-over-year revenue increase but facing operational challenges.
Lightwave Logic, Kyverna Therapeutics, and Other Major Stocks Decline in Tuesday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are down, with Dow futures falling approximately 0.2% on Tuesday morning.
Lightwave Logic Inc: Shares of Lightwave Logic Inc dropped 14.5% to $3.22 in pre-market trading following the announcement of a $35 million public offering.
Other Declining Stocks: Several other stocks also saw declines in pre-market trading, including Ascent Solar Technologies (-15.1%), Fractyl Health (-10.4%), and Ready Capital (-9%).
Market Overview: The overall market sentiment appears negative, with multiple companies reporting significant drops in their stock prices ahead of the trading day.
Major Stock Movers on Tuesday: RILY, ORGO, KYTX, RC, LWLG, and Others
Market Overview: U.S. stock futures declined as investors remained cautious ahead of November's employment data, a crucial indicator for the labor market's health.
Biggest Gainers: B. Riley Financial shares surged by 28.5% after filing its overdue Q2 report, revealing a return to profitability, while Organogenesis Holdings rose 7.5% following FDA confirmation to initiate a rolling Biologics License Application for its knee osteoarthritis treatment.
Biggest Losers: Fractyl Health's shares fell 10.71% due to the cancellation of Tranche A warrants, and Kyverna Therapeutics dropped 6.7% after announcing a $100 million public offering despite positive clinical data.
Dividend Cuts and Offerings: Ready Capital's shares declined 9.44% after a drastic 92% dividend cut, and Lightwave Logic's stock slid 14.59% following the pricing of a $35 million public offering to boost cash reserves for commercialization and strategic purposes.
